Efficacy of entrectinib in patients (pts) with solid tumors and central nervous system (CNS) metastases: Integrated analysis from three clinical trials.

Authors

Salvatore Siena

Salvatore Siena

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, and Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy

Salvatore Siena , Robert Charles Doebele , Alice Tsang Shaw , Christos Stelios Karapetis , Daniel Shao-Weng Tan , Byoung Chul Cho , Dong-Wan Kim , Myung-Ju Ahn , Matthew Krebs , Koichi Goto , Pilar Garrido Lopez , Anna F. Farago , Herbert H. F. Loong , Diego Tosi , Minal A. Barve , Brian P. Simmons , Chenglin Ye , Susan Eng , Alexander E. Drilon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics and Tumor Biology (Nonimmuno)

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Other Developmental Therapeutics

Clinical Trial Registration Number

NCT02097810; NCT02568267

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3017)

DOI

10.1200/JCO.2019.37.15_suppl.3017

Abstract #

3017

Poster Bd #

9

Abstract Disclosures

Similar Posters

First Author: Misako Nagasaka

First Author: Christian Diego Rolfo

First Author: D. Ross Camidge